Par Drugs And Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Par Drugs and Chemicals Limited has filed a routine compliance certificate with the NSE for the quarter ended March 31, 2026. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. It confirms that all share certificates received for dematerialization during the quarter were duly processed, confirmed to the depositories (NSDL and CDSL), listed on the stock exchanges, and the depositories' names were substituted in the register of members within the required timelines. The rejected certificates were mutilated and cancelled after verification. This is a standard quarterly compliance filing mandated by SEBI for companies whose shares are held in demat form.
This is a routine regulatory compliance filing with no material impact on the company's business, financials, or shareholders. It does not affect share price or shareholder value.